Response Genetics, Genetic Technologies to distribute molecular diagnostic tests globally

Register for free to listen to this article
Listen with Speechify
0:00
1:00
LOS ANGELES—Response Genetics Inc., a developer of moleculardiagnostic tests for cancer, and Genetic Technologies Ltd., a private genetictesting laboratory in Australia, announced in January an exclusive distributionand services agreement under which Genetic Technologies will become theexclusive distributor for Response Genetics' ResponseDX Colon, Lung and Gastricgenetic test panels in Australia, Indonesia, Malaysia, the Philippines,Singapore and Thailand. The tests are proprietary PCR-based tests used toanalyze the expression of genes that correlate with response to commonly usedchemotherapy agents. Financial terms were not disclosed.
  
 
   

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue